What is Translational Development Acquisition Corp.'s (TDAC) StockRank?

MoatMap's StockRank for Translational Development Acquisition Corp. (TDAC) is 14/100, with a Strong Sell signal. This is a composite score combining Quality (19), Value (32), and Momentum (51) factor ranks across MoatMap's 20,000+ stock universe.

Does Translational Development Acquisition Corp. have an economic moat?

Translational Development Acquisition Corp. (TDAC) has a Quality factor score of 19/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Translational Development Acquisition Corp. a buy, hold, or sell?

MoatMap's current signal for Translational Development Acquisition Corp. (TDAC) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Translational Development Acquisition Corp. in?

Translational Development Acquisition Corp. (TDAC) operates in the Financial Services sector, specifically the Shell Companies industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

TDAC

STRONG SELLREMOVE

Translational Development Acquisition Corp. · Financial Services · United States · $236M · Avg Vol: $2M/d

StockRank

P/E (TTM)

38.3x

ROE

—

D/E

—

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Another blank-check company with no operating business, no owner earnings, and no structural moat. It does not fit our concentrated portfolio of high-quality compounders.

COMPANY DESCRIPTION

Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC) established to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. Its competitive positioning relies on the management team's capacity to identify a promising target company within a specific industry. Operating as a non-operating shell entity, its investment appeal stems from its potential to acquire an operating business.

FINANCIAL SUMMARY (USD)

Year	2023	2024	2025	CAGR
Revenue	0	0	0	—
EPS	-0.11	-0.02	0.29	—
Shares	20M	22M	22M	+11.4%
Debt	347,500	6M	200,000	-24.1%
Equity	-507,658	169M	175M	3.8%
Op CF	-204	-851,446	-608,387	—
Inv CF	0	-174M	0	—
Fin CF	0	176M	200,000	—

PRICE (1M)+1.1%

SMA 50SMA 200

$10.75

RSI (14)

50.0

52W High

$10.80

From 52W High

1.0%

SCORE BREAKDOWN

Quality

ROIC

-0.5%8.6

ROE

—N/A

GP/Assets

—N/A

Op. Margin

0.0%12.9

FCF/Assets

-0.2%25.7

Piotroski

—20.6

Int. Cover

—N/A

D/E Ratio

—N/A

Current Ratio

0.09x4.6

Value

P/E (TTM)

38.3x9.1

EV/EBITDA

—N/A

P/FCF

—N/A

P/B

-7.3x93.6

P/S

—N/A

Div Yield

—N/A

Momentum

52W High %

100%95.2

RS 6M

-8%47.4

SMA 50/200

1.02x44.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-10%20.8

FUNDAMENTALS

Market Cap

$236M

P/E (Forward)

—

Gross Margin

0.0%

SECTOR PEERS

Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of TDAC are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
TDAC	Translational Development Acquisition Corp.(you)	$236M	14	STRONG SELL
DAAQ	Digital Asset Acquisition Corp.	$237M	15	STRONG SELL
MACI	Melar Acquisition Corp. I	$234M	13	STRONG SELL
DMAA	Drugs Made In America Acquisition Corp.	$257M	15	STRONG SELL
PLMK	Plum Acquisition Corp. IV	$258M	14	STRONG SELL
RAAQ	Real Asset Acquisition Corp.	$262M	15	STRONG SELL
VNME	Vendome Acquisition Corporation I	$255M	13	STRONG SELL
DYNC	Dynamix Corporation	$239M	12	STRONG SELL
OACC	Oaktree Acquisition Corp. III Life Sciences	$263M	13	STRONG SELL
EGHA	EGH Acquisition Corp.	$212M	16	STRONG SELL

Peer medians: ROE 10.8% · P/E 13.6x · Gross margin 0.0%

Translational Development Acquisition Corp. (TDAC) — Stock Score Summary

Translational Development Acquisition Corp. (TDAC) has a MoatMap StockRank of 14/100 based on Quality (19/100), Value (32/100), and Momentum (51/100) factor scores. The current signal is STRONG SELL. Another blank-check company with no operating business, no owner earnings, and no structural moat. It does not fit our concentrated portfolio of high-quality compounders.

Key Financial Metrics

Price	$10.75
Market Cap	$236M
P/E (TTM)	38.29
Price/Book	-7.32
Return on Invested Capital	-0.5%
Gross Margin	0.0%
Operating Margin	0.0%
Free Cash Flow	$-353K

Translational Development Acquisition Corp. operates in the Shell Companies industry, part of the Financial Services sector (United States).

Frequently Asked Questions

What is Translational Development Acquisition Corp.’s (TDAC) StockRank?: MoatMap’s StockRank for Translational Development Acquisition Corp. (TDAC) is 14/100, with a Strong Sell signal. It is a composite of Quality (19), Value (32), and Momentum (51) factor ranks across MoatMap’s 20,000+ stock universe.
Does Translational Development Acquisition Corp. have an economic moat?: Translational Development Acquisition Corp. (TDAC) has a Quality factor score of 19/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Translational Development Acquisition Corp. a buy, hold, or sell?: MoatMap’s current signal for Translational Development Acquisition Corp. (TDAC) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Translational Development Acquisition Corp. in?: Translational Development Acquisition Corp. (TDAC) operates in the Financial Services sector, specifically the Shell Companies industry (United States).